CEPACOL SORE THROAT SPRAY 0.1 %
DYCLONINE HYDROCHLORIDE : 0.1 % · DIN 02238651 · RECKITT BENCKISER (CANADA) INC
Health Canada status: CANCELLED POST MARKET
What is CEPACOL SORE THROAT SPRAY?
CEPACOL SORE THROAT SPRAY 0.1 % contains DYCLONINE HYDROCHLORIDE : 0.1 %. It is listed in the Health Canada Drug Product Database under DIN 02238651, held by RECKITT BENCKISER (CANADA) INC, supplied as SPRAY for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Mar-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02238651 |
|---|---|
| Brand name | CEPACOL SORE THROAT SPRAY |
| Generic / active ingredient | DYCLONINE HYDROCHLORIDE : 0.1 % |
| Manufacturer | RECKITT BENCKISER (CANADA) INC |
| Strength | 0.1 % |
| Dosage form | SPRAY |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R02AD04 DYCLONINE |
| AHFS class | 92:01.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Mar-2012 |
| Original market date | 1998-12-15 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02238651 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2238651 |
| Brand name | CEPACOL SORE THROAT SPRAY |
| Active ingredient / INN | DYCLONINE HYDROCHLORIDE : 0.1 % |
| ATC code | R02AD04 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R02 |
| AHFS class | 92:01.00* ; See footnote |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | RECKITT BENCKISER (CANADA) INC |
Which pack is which?
| Strength on the label | 0.1 % |
|---|---|
| Dosage form | SPRAY |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code R02AD04 DYCLONINE. 0 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SORE THROAT RELIEF | 3 MG | LOZENGE | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED PRE MARKET | DIN 02241325 |
| SUCRETS COMPLETE | 3 MG | LOZENGE | INSIGHT PHARMACEUTICALS, LLC | CANCELLED POST MARKET | DIN 02275481 |
| SUCRETS COMPLETE SORE THROAT, COUGH AND IRRITATION | 2 MG | LOZENGE | INSIGHT PHARMACEUTICALS, LLC | CANCELLED PRE MARKET | DIN 02427915 |
| SUCRETS EXTRA STRENGTH MINT FLAV.LOZ 3MG | 3 MG | LOZENGE | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 02087529 |
| SUCRETS FOR KIDS | 1.2 MG | LOZENGE | INSIGHT PHARMACEUTICALS, LLC | CANCELLED POST MARKET | DIN 02229682 |
| SUCRETS FOR KIDS | 1.2 MG | LOZENGE | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 01908693 |
| SUCRETS REGULAR STRENGTH LEMON FLAV.LOZ 2MG | 2 MG | LOZENGE | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 02088444 |
| SUCRETS REGULAR STRENGTH LEMON FLAVOURED LOZENGES | 2 MG | LOZENGE | HERITAGE BRANDS, A SUBSIDIARY OF INSIGHT PHARMACEUTICALS LLC | CANCELLED POST MARKET | DIN 02229657 |
| SUCRETS SORE THROAT | 3 MG | LOZENGE | INSIGHT PHARMACEUTICALS, LLC | CANCELLED POST MARKET | DIN 02268604 |
| SUCRETS SORE THROAT SPRAY 0.1% CHERRY | .1 % | AEROSOL | SMITHKLINE BEECHAM CONSUMER HEALTHCARE, DIVISION OF SMITHKLINE BEECHAM INC. | CANCELLED POST MARKET | DIN 01908707 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.